Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Chumakov

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Oncolytic Virotherapy|August 3, 2019
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypesSergei S Zainutdinov, Galina V Kochneva, Sergei V Netesov, et al.
Nature Medicine|November 16, 2005
The antioxidant function of the p53 tumor suppressorAnna A Sablina, Andrei V Budanov, Galina V Ilyinskaya, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: preclinical and clinical studiesOlga V Matveeva, Zong S Guo, Vyacheslav M Senin, et al.
Oncogene|July 4, 2002
Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracilElena N Pugacheva, Alexey V Ivanov, Julia E Kravchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathwayAnastasia A Khutornenko, Vladimir V Roudko, Boris V Chernyak, et al.
Cancers|July 29, 2025
Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic AdministrationViktoria A Sarkisova, Alexandra A Dalina, Daria O Neymysheva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 23, 2018
NLRX1 resides in mitochondrial RNA granules and regulates mitochondrial RNA processing and bioenergetic adaptationKritarth Singh, Lakshmi Sripada, Anastasia Lipatova, et al.
Viruses|May 27, 2026
Oncolytic Viruses for Cancer Therapy in DogsDaria O Neymysheva, Galina V Ilyinskaya, Viktoria A Sarkisova, et al.
Oncogene|January 16, 2002
Expression of prostate specific antigen (PSA) is negatively regulated by p53Katerina V Gurova, Oskar W Roklin, Vadim I Krivokrysenko, et al.
Cancer Research|June 5, 2003
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cellsKaterina V Gurova, Oskar W Rokhlin, Andrei V Budanov, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Oncolytic Virotherapy|August 3, 2019
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypesSergei S Zainutdinov, Galina V Kochneva, Sergei V Netesov, et al.
Nature Medicine|November 16, 2005
The antioxidant function of the p53 tumor suppressorAnna A Sablina, Andrei V Budanov, Galina V Ilyinskaya, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: preclinical and clinical studiesOlga V Matveeva, Zong S Guo, Vyacheslav M Senin, et al.
Oncogene|July 4, 2002
Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracilElena N Pugacheva, Alexey V Ivanov, Julia E Kravchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathwayAnastasia A Khutornenko, Vladimir V Roudko, Boris V Chernyak, et al.
Cancers|July 29, 2025
Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic AdministrationViktoria A Sarkisova, Alexandra A Dalina, Daria O Neymysheva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 23, 2018
NLRX1 resides in mitochondrial RNA granules and regulates mitochondrial RNA processing and bioenergetic adaptationKritarth Singh, Lakshmi Sripada, Anastasia Lipatova, et al.
Viruses|May 27, 2026
Oncolytic Viruses for Cancer Therapy in DogsDaria O Neymysheva, Galina V Ilyinskaya, Viktoria A Sarkisova, et al.
Oncogene|January 16, 2002
Expression of prostate specific antigen (PSA) is negatively regulated by p53Katerina V Gurova, Oskar W Roklin, Vadim I Krivokrysenko, et al.
Cancer Research|June 5, 2003
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cellsKaterina V Gurova, Oskar W Rokhlin, Andrei V Budanov, et al.
Pageof 6